Related Experiment Video

Updated: Mar 19, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.0K

Breaking a paradigm: IL-6/STAT3 signaling suppresses metastatic prostate cancer upon ARF expression

Zoran Culig1, Jan Pencik2, Olaf Merkel2

  • 1Department of Urology, Medical University of Innsbruck , Innsbruck, Austria.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Interleukin 6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) signaling plays a key role in prostate cancer (PCa) by regulating the ARF-MDM2-p53 senescence axis. This finding challenges the previously assumed oncogenic role of IL-6/STAT3 signaling in PCa.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Interleukin 6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) signaling is widely recognized for its oncogenic functions in prostate cancer (PCa).
  • The precise mechanisms by which IL-6/STAT3 signaling influences PCa progression are under continuous investigation.

Purpose of the Study:

  • To investigate the role of IL-6/STAT3 signaling in the regulation of the ARF-MDM2-p53 senescence axis in prostate cancer.
  • To re-evaluate the oncogenic properties of IL-6/STAT3 signaling in PCa based on new findings.

Main Methods:

  • Analysis of IL-6/STAT3 signaling pathways.
  • Investigation of the ARF-MDM2-p53 senescence axis.
  • Prostate cancer cell line studies.

Main Results:

  • IL-6/STAT3 signaling was found to centrally regulate the ARF-MDM2-p53 senescence axis.
  • This regulation suggests a non-oncogenic role for IL-6/STAT3 signaling in certain contexts of PCa.

Conclusions:

  • The established oncogenic role of IL-6/STAT3 signaling in prostate cancer needs re-evaluation.
  • Understanding IL-6/STAT3's role in senescence pathways has significant therapeutic implications for PCa treatment.
Keywords:
ARFCDK4/CDK6 inhibitorsIL-6MetastasisProstate cancerSTAT3Senescence

More Related Videos

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.7K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

9.0K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K